Xenetic Biosciences (XBIO) Competitors $3.08 +0.01 (+0.33%) Closing price 03:16 PM EasternExtended Trading$3.07 -0.01 (-0.32%) As of 04:01 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsOwnershipSEC FilingsShort InterestTrendsBuy This Stock XBIO vs. LEXX, CMMB, ALLR, TXMD, BFRG, GLYC, PMN, HOOK, COCP, and CINGShould you be buying Xenetic Biosciences stock or one of its competitors? The main competitors of Xenetic Biosciences include Lexaria Bioscience (LEXX), Chemomab Therapeutics (CMMB), Allarity Therapeutics (ALLR), TherapeuticsMD (TXMD), Bullfrog AI (BFRG), GlycoMimetics (GLYC), ProMIS Neurosciences (PMN), Hookipa Pharma (HOOK), Cocrystal Pharma (COCP), and Cingulate (CING). These companies are all part of the "pharmaceutical preparations" industry. Xenetic Biosciences vs. Lexaria Bioscience Chemomab Therapeutics Allarity Therapeutics TherapeuticsMD Bullfrog AI GlycoMimetics ProMIS Neurosciences Hookipa Pharma Cocrystal Pharma Cingulate Xenetic Biosciences (NASDAQ:XBIO) and Lexaria Bioscience (NASDAQ:LEXX) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, analyst recommendations, institutional ownership, media sentiment, profitability, community ranking, risk, earnings and dividends. Which has more risk & volatility, XBIO or LEXX? Xenetic Biosciences has a beta of 2.31, suggesting that its share price is 131% more volatile than the S&P 500. Comparatively, Lexaria Bioscience has a beta of 0.9, suggesting that its share price is 10% less volatile than the S&P 500. Is XBIO or LEXX more profitable? Xenetic Biosciences has a net margin of -161.63% compared to Lexaria Bioscience's net margin of -1,473.04%. Xenetic Biosciences' return on equity of -49.51% beat Lexaria Bioscience's return on equity.Company Net Margins Return on Equity Return on Assets Xenetic Biosciences-161.63% -49.51% -43.99% Lexaria Bioscience -1,473.04%-88.88%-83.59% Does the MarketBeat Community prefer XBIO or LEXX? Xenetic Biosciences received 167 more outperform votes than Lexaria Bioscience when rated by MarketBeat users. However, 100.00% of users gave Lexaria Bioscience an outperform vote while only 66.92% of users gave Xenetic Biosciences an outperform vote. CompanyUnderperformOutperformXenetic BiosciencesOutperform Votes17466.92% Underperform Votes8633.08% Lexaria BioscienceOutperform Votes7100.00% Underperform VotesNo Votes Do insiders & institutionals have more ownership in XBIO or LEXX? 15.1% of Xenetic Biosciences shares are owned by institutional investors. Comparatively, 13.1% of Lexaria Bioscience shares are owned by institutional investors. 14.7% of Xenetic Biosciences shares are owned by insiders. Comparatively, 26.4% of Lexaria Bioscience shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Do analysts prefer XBIO or LEXX? Lexaria Bioscience has a consensus price target of $7.00, suggesting a potential upside of 536.36%. Given Lexaria Bioscience's stronger consensus rating and higher possible upside, analysts clearly believe Lexaria Bioscience is more favorable than Xenetic Biosciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Xenetic Biosciences 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00Lexaria Bioscience 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has higher valuation & earnings, XBIO or LEXX? Xenetic Biosciences has higher revenue and earnings than Lexaria Bioscience. Lexaria Bioscience is trading at a lower price-to-earnings ratio than Xenetic Biosciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioXenetic Biosciences$2.58M1.84-$4.14M-$2.38-1.29Lexaria Bioscience$525.92K36.73-$5.80M-$0.59-1.86 Does the media prefer XBIO or LEXX? In the previous week, Xenetic Biosciences had 3 more articles in the media than Lexaria Bioscience. MarketBeat recorded 3 mentions for Xenetic Biosciences and 0 mentions for Lexaria Bioscience. Xenetic Biosciences' average media sentiment score of 1.04 beat Lexaria Bioscience's score of 0.00 indicating that Xenetic Biosciences is being referred to more favorably in the media. Company Overall Sentiment Xenetic Biosciences Positive Lexaria Bioscience Neutral SummaryXenetic Biosciences beats Lexaria Bioscience on 11 of the 18 factors compared between the two stocks. Get Xenetic Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for XBIO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart XBIO vs. The Competition Export to ExcelMetricXenetic BiosciencesPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$4.75M$6.48B$5.34B$8.31BDividend YieldN/A2.64%5.20%4.10%P/E Ratio-1.168.4426.7719.60Price / Sales1.84258.77395.56117.92Price / CashN/A65.8538.3234.62Price / Book0.486.416.764.50Net Income-$4.14M$143.73M$3.23B$248.32M7 Day Performance5.84%0.31%0.40%-1.00%1 Month Performance23.15%2.02%9.11%10.76%1 Year Performance-19.72%-0.66%18.69%9.01% Xenetic Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)XBIOXenetic Biosciences1.0611 of 5 stars$3.08+0.3%N/A-24.5%$4.75M$2.58M-1.164Positive NewsLEXXLexaria Bioscience1.9933 of 5 stars$1.08-0.5%$7.00+551.2%-64.7%$18.88M$525,923.00-2.157Gap UpCMMBChemomab Therapeutics3.0458 of 5 stars$1.24-1.6%$9.00+625.8%+61.9%$17.81MN/A-1.2420ALLRAllarity Therapeutics0.1353 of 5 stars$1.02-2.9%N/A-94.5%$17.42MN/A0.0010Analyst UpgradeGap DownTXMDTherapeuticsMD0.8977 of 5 stars$1.48+1.4%N/A-32.2%$16.90M$1.76M0.00420News CoveragePositive NewsAnalyst ForecastBFRGBullfrog AI0.4644 of 5 stars$1.77+0.6%N/A-39.3%$16.67M$60,000.00-2.084Positive NewsGap UpGLYCGlycoMimetics1.2593 of 5 stars$0.26+6.9%N/A-12.2%$16.57M$10,000.00-0.4450Gap DownPMNProMIS Neurosciences1.6084 of 5 stars$0.50-0.2%$4.50+798.2%-69.4%$16.38MN/A-5.015Gap UpHigh Trading VolumeHOOKHookipa Pharma2.0257 of 5 stars$1.34+3.1%$23.00+1,616.4%-83.5%$16.16M$43.95M-0.3656News CoverageCOCPCocrystal Pharma3.2682 of 5 stars$1.57+3.0%$7.00+347.3%-29.1%$15.92MN/A-0.8510News CoverageAnalyst RevisionGap UpCINGCingulate2.1161 of 5 stars$3.98-0.7%$30.67+670.5%+338.5%$15.69MN/A-0.4720Analyst Revision Related Companies and Tools Related Companies LEXX Competitors CMMB Competitors ALLR Competitors TXMD Competitors BFRG Competitors GLYC Competitors PMN Competitors HOOK Competitors COCP Competitors CING Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:XBIO) was last updated on 5/23/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredSilver Is the New Oil—And the World’s Running DryElon's Next Market Move Could Send Silver Soaring Every industry Elon Musk touches explodes—from Tesla to S...Priority Gold | SponsoredTrump’s Bitcoin Reserve is No Accident…Bitcoin's supply is being drained at unprecedented rates, but while most investors focus solely on Bitcoin, th...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Xenetic Biosciences Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Xenetic Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy XBIO Stock Free XBIO Stock Alerts